Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wansbrough-Jones

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Journal of Infection|February 11, 2010
Positive predictive value of the UK clinical case definition for H1N1/09 ('swine') influenzaT Bicanic, A W Solomon, N Karunaharan, et al.
Infection and Immunity|April 20, 2006
Cytokine mRNA expression in Mycobacterium ulcerans-infected human skin and correlation with local inflammatory responseR Phillips, C Horsfield, J Mangan, et al.
Journal of Clinical Microbiology|February 11, 2009
Sensitivity of PCR targeting Mycobacterium ulcerans by use of fine-needle aspirates for diagnosis of Buruli ulcerR O Phillips, F S Sarfo, F Osei-Sarpong, et al.
Journal of Clinical Microbiology|August 6, 2005
Sensitivity of PCR targeting the IS2404 insertion sequence of Mycobacterium ulcerans in an Assay using punch biopsy specimens for diagnosis of Buruli ulcerR Phillips, C Horsfield, S Kuijper, et al.
Clinical and Vaccine Immunology : CVI|February 10, 2006
Cytokine response to antigen stimulation of whole blood from patients with Mycobacterium ulcerans disease compared to that from patients with tuberculosisR Phillips, C Horsfield, S Kuijper, et al.
Journal of Medical Case Reports|July 19, 2019
Providing insight into the incubation period of Mycobacterium ulcerans disease: two case reportsY A Amoako, M Frimpong, D O Awuah, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2005
Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humansS Etuaful, B Carbonnelle, J Grosset, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Journal of Infection|February 11, 2010
Positive predictive value of the UK clinical case definition for H1N1/09 ('swine') influenzaT Bicanic, A W Solomon, N Karunaharan, et al.
Infection and Immunity|April 20, 2006
Cytokine mRNA expression in Mycobacterium ulcerans-infected human skin and correlation with local inflammatory responseR Phillips, C Horsfield, J Mangan, et al.
Journal of Clinical Microbiology|February 11, 2009
Sensitivity of PCR targeting Mycobacterium ulcerans by use of fine-needle aspirates for diagnosis of Buruli ulcerR O Phillips, F S Sarfo, F Osei-Sarpong, et al.
Journal of Clinical Microbiology|August 6, 2005
Sensitivity of PCR targeting the IS2404 insertion sequence of Mycobacterium ulcerans in an Assay using punch biopsy specimens for diagnosis of Buruli ulcerR Phillips, C Horsfield, S Kuijper, et al.
Clinical and Vaccine Immunology : CVI|February 10, 2006
Cytokine response to antigen stimulation of whole blood from patients with Mycobacterium ulcerans disease compared to that from patients with tuberculosisR Phillips, C Horsfield, S Kuijper, et al.
Journal of Medical Case Reports|July 19, 2019
Providing insight into the incubation period of Mycobacterium ulcerans disease: two case reportsY A Amoako, M Frimpong, D O Awuah, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2005
Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humansS Etuaful, B Carbonnelle, J Grosset, et al.
Pageof 2